Delcath Systems Inc (DCTH)

[SAMNOTSAMUEL]

Primary risk imo is excessive dilution. I would love to know more about ICC potential, but based on history probably enrollment will be more likely to complete in September. If you take another read of clinicaltrials.gove, it is likely 12 month from full enrollment to completed trial. Maybe FDA will surprise saying start submission early.

My best guess thus is Sep 2020 for end of trial and possibly Sep 2021 before approval.

I think the only path to 2019 buyout is delcath has to be saved by a low ball offer which still might be profitable from this price, but nobody knows